Rua Bioscience Limited engages in the research, development, and manufacturing of pharmaceutical products in New Zealand and internationally. It offers cannabinoid derived medicines. The company was formerly known as Hikurangi Cannabis Company Limited and changed its name to Rua Bioscience Limited in October 2019. Rua Bioscience Limited was founded in 2016 and is based in Gisborne, New Zealand.
Stock data | 2023 | Change |
---|---|---|
Price | $0.028542885685742828 | N/A |
Market Cap | $4.51M | N/A |
Shares Outstanding | 158.14M | 9.69% |
Employees | 0 | N/A |
Shareholder Equity | 20.12M | -16.85% |
Valuation | 2023 | Change |
---|---|---|
P/S Ratio | 20.34 | N/A |
P/B Ratio | 0.22 | N/A |
P/FCF | -1.21 | N/A |
Growth | 2023 | Change |
---|---|---|
CAPEX | -24.15K | N/A |
Return on Equity | -0.1838 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $221.94K | N/A |
Earnings | -$3.70M | N/A |
Free Cash Flow | -$3.72M | N/A |
Gross Margin | 0.0507 | N/A |
Operating Margin | -36.35 | N/A |
Net income margin | -16.66 | N/A |
FCF Margin | -16.76 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $13.00M | N/A |
Total Debt | $71.09K | N/A |
Cash on Hand | $2.83M | N/A |
Debt to Equity | 0.0256 | -89.35% |
Cash to Debt | $39.81 | 230.06% |
Current Ratio | $7.35 | 213.33% |